
"Sector" = median of Healthcare across 84 companies
Cencora, Inc. is a leading global pharmaceutical services and distribution company, formerly known as AmerisourceBergen. It partners with manufacturers, pharmacies, and healthcare providers to deliver innovative solutions that improve patient access to medications. The company operates primarily in the US and Canada, with a growing international presence.
Cencora generates revenue through pharmaceutical distribution, which accounts for the vast majority of sales. It sources branded and generic drugs, over-the-counter products, and specialty pharmaceuticals from manufacturers and distributes them to retail pharmacies, hospitals, clinics, and other healthcare settings. The company also provides value-added services such as patient support programs, data analytics, and supply chain consulting.
The medical distribution industry is highly consolidated, with Cencora competing against major players like McKesson and Cardinal Health. Cencora differentiates itself through its specialty logistics capabilities, particularly in oncology and rare diseases, and its focus on independent pharmacies. The sector faces thin margins and regulatory pressures, but steady demand for pharmaceuticals provides stability.
Cencora's primary customers include retail pharmacy chains (e.g., CVS, Walgreens), independent pharmacies, hospitals, and physician offices. Its main geographic market is the United States, where it holds a significant market share. The company also serves customers in Canada and select international markets. Revenue is diversified across thousands of clients, with no single customer representing excessive concentration.
An auto-generated descriptive profile based on company data, for informational purposes only.
No 24-hour summary has been generated yet.
Latest saved period: March 2026 · 2026-03-31
Cash dividends by ex-date, not an investment recommendation.
| Ex-date | Amount | Payment date | Period |
|---|---|---|---|
| Feb 13, 2026 | $0.60 | Mar 2, 2026 | Quarterly |
| Nov 14, 2025 | $0.60 | Dec 1, 2025 | Quarterly |
| Aug 15, 2025 | $0.55 | Sep 3, 2025 | Quarterly |
| May 16, 2025 | $0.55 | Jun 2, 2025 | Quarterly |
| Feb 14, 2025 | $0.55 | Mar 3, 2025 | Quarterly |
| Nov 15, 2024 | $0.55 | Nov 29, 2024 | Quarterly |
| Aug 9, 2024 | $0.51 | Aug 26, 2024 | Quarterly |
| May 9, 2024 | $0.51 | May 24, 2024 | Quarterly |
| Feb 8, 2024 | $0.51 | Feb 26, 2024 | Quarterly |
| Nov 10, 2023 | $0.51 | Nov 27, 2023 | Quarterly |
| Aug 10, 2023 | $0.49 | Aug 28, 2023 | Quarterly |
| May 11, 2023 | $0.49 | May 30, 2023 | Quarterly |
| Feb 9, 2023 | $0.49 | Feb 27, 2023 | Quarterly |
| Nov 10, 2022 | $0.49 | Nov 28, 2022 | Quarterly |
| Aug 12, 2022 | $0.46 | Aug 29, 2022 | Quarterly |
| May 13, 2022 | $0.46 | May 31, 2022 | Quarterly |
| Feb 11, 2022 | $0.46 | Feb 28, 2022 | Quarterly |
| Nov 12, 2021 | $0.46 | Nov 29, 2021 | Quarterly |
| Aug 13, 2021 | $0.44 | Sep 7, 2021 | Quarterly |
| May 14, 2021 | $0.44 | Jun 1, 2021 | Quarterly |
| Feb 11, 2021 | $0.44 | Mar 1, 2021 | Quarterly |
| Nov 13, 2020 | $0.44 | Nov 30, 2020 | Quarterly |
| Aug 14, 2020 | $0.42 | Sep 1, 2020 | Quarterly |
| May 15, 2020 | $0.42 | Jun 1, 2020 | Quarterly |
Wrqti brings Cencora, Inc. data into one page covering available price, financial statements, valuation ratios, margins, cash-flow metrics, news, and alerts. This page helps you understand the numbers and is not a buy or sell recommendation.
Companies in the Healthcare sector you can compare with Cencora, Inc.:
When available, the page shows quarterly and annual statements plus ratios such as PE, price to book, profit margin, and free cash flow. Latest financial period shown: March 2026.
Wrqti content depends on available data and third-party sources and may include delays or errors. Review official company filings and consult a licensed financial advisor before making investment decisions. Read the data methodology.